| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TISSUE-SPECIFIC STEM CELLS |
a Department of Medicine, University of Alberta, Edmonton, Alberta, Canada;
b Canadian Blood Services Research & Development, Edmonton, Alberta, Canada;
c University of Louisville, Louisville, Kentucky, USA
Key Words. Mesenchymal stem cells • Cord blood • Bone marrow • Matrix metalloproteinases • Membrane type 1-matrix metalloproteinase • Gene expression
Correspondence: Anna Janowska-Wieczorek, M.D., Ph.D., Department of Medicine, University of Alberta, CBS Building, 8249 114 St., Edmonton, AB T6G 2R8, Canada. Telephone: 780-431-8761; Fax: 780-702-8622; e-mail: anna.janowska{at}bloodservices.ca
Received June 15, 2005;
accepted for publication January 5, 2006.
Human mesenchymal stem cells (MSCs) are increasingly being considered in cell-based therapeutic strategies for regeneration of various organs/tissues. However, the signals required for their homing and recruitment to injured sites are not yet fully understood. Because stromal-derived factor (SDF)-1 and hepatocyte growth factor (HGF) become up-regulated during tissue/organ damage, in this study we examined whether these factors chemoattract ex vivo-expanded MSCs derived from bone marrow (BM) and umbilical cord blood (CB). Specifically, we investigated the expression by MSCs of CXCR4 and c-met, the cognate receptors of SDF-1 and HGF, and their functionality after early and late passages of MSCs. We also determined whether MSCs express matrix metalloproteinases (MMPs), including membrane type 1 (MT1)-MMP, matrix-degrading enzymes that facilitate the trafficking of hematopoietic stem cells. We maintained expanded BM- or CB-derived MSCs for up to 15–18 passages with monitoring of the expression of 1) various tissue markers (cardiac and skeletal muscle, neural, liver, and endothelial cells), 2) functional CXCR4 and c-met, and 3) MMPs. We found that for up to 15–18 passages, both BM- and CB-derived MSCs 1) express mRNA for cardiac, muscle, neural, and liver markers, as well as the vascular endothelial (VE) marker VE-cadherin; 2) express CXCR4 and c-met receptors and are strongly attracted by SDF-1 and HGF gradients; 3) express MMP-2 and MT1-MMP transcripts and proteins; and 4) are chemo-invasive across the reconstituted basement membrane Matrigel. These in vitro results suggest that the SDF-1-CXCR4 and HGF-c-met axes, along with MMPs, may be involved in recruitment of expanded MSCs to damaged tissues.
This article has been cited by other articles:
|
|
 |
|
  T. Trapp, G. Kogler, A. El-Khattouti, R. V. Sorg, M. Besselmann, M. Focking, C. P. Buhrle, I. Trompeter, J. C. Fischer, and P. Wernet Hepatocyte Growth Factor/c-MET Axis-mediated Tropism of Cord Blood-derived Unrestricted Somatic Stem Cells for Neuronal Injury J. Biol. Chem., November 21, 2008; 283(47): 32244 - 32253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kyriakou, N. Rabin, A. Pizzey, A. Nathwani, and K. Yong Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model Haematologica, October 1, 2008; 93(10): 1457 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Liebler, C. Lutzko, A. Banfalvi, D. Senadheera, N. Aghamohammadi, E. D. Crandall, and Z. Borok Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L285 - L292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Rosova, M. Dao, B. Capoccia, D. Link, and J. A. Nolta Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells Stem Cells, August 1, 2008; 26(8): 2173 - 2182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop Stem Cells and Cell Therapies in Lung Biology and Lung Diseases Proceedings of the ATS, July 15, 2008; 5(5): 637 - 667. [Full Text] [PDF]
|
|
|
|
|
|
M. Gutova, J. Najbauer, R. T. Frank, S. E. Kendall, A. Gevorgyan, M. Z. Metz, M. Guevorkian, M. Edmiston, D. Zhao, C. A. Glackin, et al. Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Mediate Human Stem Cell Tropism to Malignant Solid Tumors Stem Cells, June 1, 2008; 26(6): 1406 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Marquez-Curtis, A. Jalili, K. Deiteren, N. Shirvaikar, A.-M. Lambeir, and A. Janowska-Wieczorek Carboxypeptidase M Expressed by Human Bone Marrow Cells Cleaves the C-Terminal Lysine of Stromal Cell-Derived Factor-1{alpha}: Another Player in Hematopoietic Stem/Progenitor Cell Mobilization? Stem Cells, May 1, 2008; 26(5): 1211 - 1220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Sonabend, I. V. Ulasov, M. A. Tyler, A. A. Rivera, J. M. Mathis, and M. S. Lesniak Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma Stem Cells, March 1, 2008; 26(3): 831 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-P. Chen, M.-Y. Lee, J.-P. Huang, J. D. Aplin, Y.-H. Wu, C.-S. Hu, P.-C. Chen, H. Li, S.-M. Hwang, S.-H. Liu, et al. Trafficking of Multipotent Mesenchymal Stromal Cells from Maternal Circulation Through the Placenta Involves Vascular Endothelial Growth Factor Receptor-1 and Integrins Stem Cells, February 1, 2008; 26(2): 550 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Hoelzinger, T. Demuth, and M. E. Berens Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment J Natl Cancer Inst, November 7, 2007; 99(21): 1583 - 1593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cui, J. Chen, A. Zacharek, Y. Li, C. Roberts, A. Kapke, S. Savant-Bhonsale, and M. Chopp Nitric Oxide Donor Upregulation of Stromal Cell-Derived Factor-1/Chemokine (CXC Motif) Receptor 4 Enhances Bone Marrow Stromal Cell Migration into Ischemic Brain After Stroke Stem Cells, November 1, 2007; 25(11): 2777 - 2785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sengenes, A. Miranville, M. Maumus, S. de Barros, R. Busse, and A. Bouloumie Chemotaxis and Differentiation of Human Adipose Tissue CD34+/CD31 Progenitor Cells: Role of Stromal Derived Factor-1 Released by Adipose Tissue Capillary Endothelial Cells Stem Cells, September 1, 2007; 25(9): 2269 - 2276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kasper, J. D. Glaeser, S. Geissler, A. Ode, J. Tuischer, G. Matziolis, C. Perka, and G. N. Duda Matrix Metalloprotease Activity Is an Essential Link Between Mechanical Stimulus and Mesenchymal Stem Cell Behavior Stem Cells, August 1, 2007; 25(8): 1985 - 1994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sathyanarayana, M. P. Menon, O. Bogacheva, O. Bogachev, K. Niss, W. S. Kapelle, E. Houde, J. Fang, and D. M. Wojchowski Erythropoietin modulation of podocalyxin and a proposed erythroblast niche Blood, July 15, 2007; 110(2): 509 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Ponte, E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, and J. Domenech The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities Stem Cells, July 1, 2007; 25(7): 1737 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xin, M. Kanehira, H. Mizuguchi, T. Hayakawa, T. Kikuchi, T. Nukiwa, and Y. Saijo Targeted Delivery of CX3CL1 to Multiple Lung Tumors by Mesenchymal Stem Cells Stem Cells, July 1, 2007; 25(7): 1618 - 1626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y N Kallis, M R Alison, and S J Forbes Bone marrow stem cells and liver disease Gut, May 1, 2007; 56(5): 716 - 724. [Full Text] [PDF]
|
|
|
|
|
|
C. Ries, V. Egea, M. Karow, H. Kolb, M. Jochum, and P. Neth MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines Blood, May 1, 2007; 109(9): 4055 - 4063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. De Becker, P. Van Hummelen, M. Bakkus, I. Vande Broek, J. De Wever, M. De Waele, and I. Van Riet Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3 Haematologica, April 1, 2007; 92(4): 440 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Deshane, S. Chen, S. Caballero, A. Grochot-Przeczek, H. Was, S. Li Calzi, R. Lach, T. D. Hock, B. Chen, N. Hill-Kapturczak, et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism J. Exp. Med., March 19, 2007; 204(3): 605 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Walter, U. Rochwalsky, J. Reinhold, F. Seeger, A. Aicher, C. Urbich, I. Spyridopoulos, J. Chun, V. Brinkmann, P. Keul, et al. Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 275 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Giacobini, A. Messina, S. Wray, C. Giampietro, T. Crepaldi, P. Carmeliet, and A. Fasolo Hepatocyte Growth Factor Acts as a Motogen and Guidance Signal for Gonadotropin Hormone-Releasing Hormone-1 Neuronal Migration J. Neurosci., January 10, 2007; 27(2): 431 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wang, P. R. Crisostomo, C. Herring, K. K. Meldrum, and D. R. Meldrum Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R880 - R884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mannello Commentary: Multipotent Mesenchymal Stromal Cell Recruitment, Migration, and Differentiation: What Have Matrix Metalloproteinases Got to Do with It? Stem Cells, August 1, 2006; 24(8): 1904 - 1907. [Full Text] [PDF]
|
|
|
|
|
|
P. Neth, M. Ciccarella, V. Egea, J. Hoelters, M. Jochum, and C. Ries Wnt Signaling Regulates the Invasion Capacity of Human Mesenchymal Stem Cells Stem Cells, August 1, 2006; 24(8): 1892 - 1903. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
